期刊文献+
共找到49篇文章
< 1 2 3 >
每页显示 20 50 100
Design,delivery and efficacy testing of therapeutic nucleic acids used to inhibit hepatitis C virus gene expression in vitro and in vivo 被引量:9
1
作者 Wolfgang H.Caselmann Matthias Serwe +3 位作者 Thomas Lehmann János Ludwig Brian S.Sproat Joachim W.Engels 《World Journal of Gastroenterology》 SCIE CAS CSCD 2000年第5期626-629,共4页
Despite major achievements in the treatment ofchronic hepatitis C with the combination ofinterferons and the nucleoside analog ribavirin themajority of patients with chronic hepatitis C virus(HCV) infection cannot be ... Despite major achievements in the treatment ofchronic hepatitis C with the combination ofinterferons and the nucleoside analog ribavirin themajority of patients with chronic hepatitis C virus(HCV) infection cannot be treated effectively.Toimprove this response rate we used antisensetechnologies to inhibit HCV translation as possibleadditional option for experimental treatment.Antisense oligodeoxynucleotides(ODN) are 展开更多
关键词 hepatitis C-like viruses/therapy gene expression in VITRO in vivo nucleic acids/therapeutic use CYTOMEGALOVIRUS
下载PDF
Therapeutic and Medicinal Uses of <i>Aloe vera</i>: A Review 被引量:5
2
作者 Pankaj K. Sahu Deen Dayal Giri +5 位作者 Ritu Singh Priyanka Pandey Sharmistha Gupta Atul Kumar Shrivastava Ajay Kumar Kapil Dev Pandey 《Pharmacology & Pharmacy》 2013年第8期599-610,共12页
The plant Aloe vera is used in Ayurvedic, Homoeopathic and Allopathic streams of medicine, and not only tribal community but also most of the people for food and medicine. The plant leaves contains numerous vitamins, ... The plant Aloe vera is used in Ayurvedic, Homoeopathic and Allopathic streams of medicine, and not only tribal community but also most of the people for food and medicine. The plant leaves contains numerous vitamins, minerals, enzymes, amino acids, natural sugars and other bioactive compounds with emollient, purgative, anti-microbial, anti inflammatory, antioxidant, aphrodisiac, anti-helmenthic, antifungal, antiseptic and cosmetic values for health care. This plant has potential to cure sunburns, burns and minor cuts, and even skin cancer. The external use in cosmetic primarily acts as skin healer and prevents injury of epithelial tissues, cures acne and gives a youthful glow to skin, also acts as extremely powerful laxative. 展开更多
关键词 ALOE vera Antimicrobial therapeutic MEDICINAL useS Cosmetic Application
下载PDF
Continuous Wear of Hydrogel Contact Lenses for Therapeutic Use
3
作者 Daisuke Kudo Hiroshi Toshida +1 位作者 Toshihiko Ohta Akira Murakami 《Open Journal of Ophthalmology》 2012年第4期110-113,共4页
Purpose: To investigate the efficacy and complications of continuous wear of etafilcon A for therapeutic use. Materials and Methods: The subjects were 228 eyes of 219 outpatients prescribed contact lens (CL) for one w... Purpose: To investigate the efficacy and complications of continuous wear of etafilcon A for therapeutic use. Materials and Methods: The subjects were 228 eyes of 219 outpatients prescribed contact lens (CL) for one week of continuous therapeutic wear during 10 years. The reason for prescription of CLs, the primary disease, the duration of CL wear and the complications were assessed retrospectively. Results: The predominant reason for prescription of CLs was relief of pain or a foreign-body sensation (62.3%) and protection of the corneal epithelium (20.6%). The primary disease was post-penetrating keratoplasty (36.8%), followed by corneal epithelial erosion (14.5%), post-lamellar keratoplasty (14.0%) and bullous keratopathy (12.2%). The average duration of wearing single lens was 6.5 ± 3.2 days. The average duration of wearing CLs in total was 9.2 ± 10.7 months. The most frequent problem associated with continuous wear of CLs was their dropping out of CLs (12.3%). The complications associated with CLs included conjunctivitis with papillary hyperplasia, corneal erosion and superficial punctate keratitis, but corneal ulcer and corneal infiltrates were not found. Conclusion: Serious complications were not shown changing the lenses every week to keep to the prescribed time limit for continuous therapeutic wear, even if corneal epithelial barrier function is impaired. 展开更多
关键词 therapeutic use BANDAGE Soft Contact LENS CONTINUOUS WEAR COMPLICATION
下载PDF
Comparison of long-lasting therapeutic effects between succimer and penicillamine on hepatolenticular degeneration 被引量:3
4
作者 REN Ming Shan, ZHANG Zhi, WU Jun Xia, LI Fei, XUE Ben Chun and YANG Ren Min 《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第6期75-77,共3页
AIM To compare the long term effect of succimer (Suc) with that of penicillamine (Pen) in treating hepatolenticular degeneration (HLD). METHODS One hundred and twenty patients with HLD were divided into 2 groups. ... AIM To compare the long term effect of succimer (Suc) with that of penicillamine (Pen) in treating hepatolenticular degeneration (HLD). METHODS One hundred and twenty patients with HLD were divided into 2 groups. Group A ( n =60) received Suc 750mg , po. bid. Group B ( n =60) received Pen 250mg , po. qid. The period of maintenance treatment varied from 6 months to 3 years, averaging 1 5 years. Symptoms and therapeutic effects were evaluated by modified Goldstein scale. RESULTS The total effectiveness of group A in two different periods of treatment were 80% and 85% respectively, higher than those of group B (58% and 59% respectively) ( P <0 05). Suc also had obvious curative effects for the patients who failed in the use of Pen. There were fewer side effect in group A than in group B ( P <0 05). Suc and Pen could increase urinary copper excretion effectively and continually. CONCLUSION Suc is more effective and safer than Pen. Clinically, it can replace Pen as first choice drug for long term maintenance therapy of HLD. 展开更多
关键词 hepatolenticular degeneration/drug THERAPY succimer/therapeutic use penicillamine/therapeutic use
下载PDF
Functional dyspepsia of ulcer-dysmotility type:clinical incidence and therapeutic strategy 被引量:3
5
作者 WANG XiaoZhong and LIN GuZhen 《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第4期95-96,共2页
Functionaldyspepsiaofulcerdysmotilitytype:clinicalincidenceandtherapeuticstrategyWANGXiaoZhongandLINGuZhe... Functionaldyspepsiaofulcerdysmotilitytype:clinicalincidenceandtherapeuticstrategyWANGXiaoZhongandLINGuZhenSubjectheaadings... 展开更多
关键词 dyspepsia/drug therapy famotidine/therapeutic use cisapride/therapeutic use peptic ULCER gastrointestinal motility
下载PDF
Therapeutic role of template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract 被引量:5
6
作者 Tsunenori Kondo Toshio Takagi Kazunari Tanabe 《World Journal of Clinical Oncology》 CAS 2015年第6期237-251,共15页
Lymphadenectomy for urothelial carcinoma of the upper urinary tract has attracted the attention of physicians. The mapping study of lymphatic spread has shown that a relatively wide area should comprise the regional n... Lymphadenectomy for urothelial carcinoma of the upper urinary tract has attracted the attention of physicians. The mapping study of lymphatic spread has shown that a relatively wide area should comprise the regional nodes for tumors of the right renal pelvis or the right upper two-thirds of the ureter. A prospective study showed that an anatomical templatebased lymphadenectomy significantly improved patient survival in tumors of the renal pelvis. This benefit was more evident for patients with p T2 stage tumors or higher. The risk of regional node recurrence is significant reduced by template-based lymphadenectomy,which is likely to be associated with improved patient survival. The removal of lymph node micrometastases is assumed to be the reason for therapeutic benefit following lymphadenectomy. The number of resected lymph nodes can be used to assess the quality of lymphadenectomy,but not to determine the extent of lymphadenectomy. The guidelines currently recommend lymphadenectomy for patients with muscle-invasive disease,even though the current recommendation grades are still low. The present limitation of lymphadenectomy is the lack of standardization of the extent of lymphadenectomy and the randomized trials. Further studies are warranted to collect the evidence to support lymphadenectomy. 展开更多
关键词 LYMPHADENECTOMY LYMPH node EXCISION UROTHELIAL carcinoma Treatment outcome therapeutic uses Diagnosis GUIDELINE
下载PDF
Blastocystis hominis as a cause of chronic diarrhea in low-resource settings:A systematic review
7
作者 Stephen Amoak Jonathan Soldera 《World Journal of Meta-Analysis》 2024年第3期30-41,共12页
BACKGROUND Blastocystis hominis(B.hominis),an anaerobic unicellular protist parasite,is known for its diverse clinical manifestations upon infecting the human gastrointestinal tract.Although globally distributed,it is... BACKGROUND Blastocystis hominis(B.hominis),an anaerobic unicellular protist parasite,is known for its diverse clinical manifestations upon infecting the human gastrointestinal tract.Although globally distributed,it is particularly prevalent in developing nations.Examining the symptoms and treatment outcomes of B.hominis infection in low-resource settings holds immense significance,providing healthcare practi-tioners with valuable insights to enhance patient care.AIM To synthesize existing evidence on the symptomatology and treatment outcomes of B.hominis infection in low-resource settings.METHODS Following the Preferred Reporting Items for Systematic Review and Meta-Analysis guidelines,a systematic review was conducted.The search spanned electronic databases including PubMed,Scopus,and Google Scholar.After a comprehensive screening process,a thorough examination of the papers,adhering to inclusion and exclusion criteria,and data extraction from eligible studies was conducted.The findings underwent summarization through simple descriptive analysis.RESULTS The search yielded 1200 papers,with 17 meeting inclusion criteria.Chronic diarrhea due to B.hominis infection was reported in only two studies,while abdominal pain,diarrhea,flatulence,constipation,and nausea/vomiting emerged as the most commonly documented symptoms.Recovery rates after one week of treatment ranged from 71.8%to 100%,and after two weeks,from 60%to 100%.CONCLUSION In low-resource settings,chronic diarrhea resulting from B.hominis infection is infrequent.Common symptoms include abdominal pain,diarrhea,flatulence,constipation,and nausea/vomiting.Post-treatment,clinical outcomes are notably favorable,supporting the recommendation for treatment.Metronidazole is advocated as the first-line agent,with consideration for switching to a second-line option in cases of treatment failure or poor response. 展开更多
关键词 Blastocystis infections Gastrointestinal diseases Treatment outcome Developing countries Metronidazole/therapeutic use
下载PDF
Clinacanthus nutans:a review of the medicinal uses,pharmacology and phytochemistry 被引量:10
8
作者 Md.Ariful Alam Sahena Ferdosh +4 位作者 Kashif Ghafoor Md.Abdul Hakim Abdul Shukor Juraimi Alfi Khatib Md.Zaidul I.Sarker 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2016年第4期393-399,共7页
Clinacanthus nutans Lindau is known as snake grass belonging to the Acanlhaceae family.This plant has diverse and potential medicinal uses in traditional herbal medicine for treating skin rashes,insects and snake bite... Clinacanthus nutans Lindau is known as snake grass belonging to the Acanlhaceae family.This plant has diverse and potential medicinal uses in traditional herbal medicine for treating skin rashes,insects and snake bites,lesions caused by herpes simplex virus,diabetes,and gout in Malaysia.Indonesia.Thailand and China.Phylochemieal investigations documented the varied contents of bioaclive compounds from litis plant namely flavonoids,glycosides,glycoglyeerolipids.cerebrosides and monoacylmonogalatosylglycerol.The pharmacological experiment proved that various types of extracts and pure compounds from this species exhibited a broad range of biological properties such as anti-inflammatory,antiviral,antioxidant,and anti-diabetic activities.The lindings of toxicity study showed that extracts from this plant did not show any toxicity thus it can be used as strong therapeutic agents for specific diseased conditions.However,further experiments on chemical components and their mode of action showing biological activities are required to elucidate the complete phytochemical profile and assess to confirm their suitability tor future drugs.This review summarizes the medicinal uses,phytochemistry and pharmacology of this plant in order to explore its therapeutic potential and gaps necessitating for prospected research work. 展开更多
关键词 Clinacanthus nutans MEDICINAL useS PHYTOCHEMICALS PHARMACOLOGY therapeutic potential
下载PDF
High-intensity focused ultrasound extracorporeal ablation of liver tissuesin rabbits
9
《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第2期16-16,共1页
HighintensityfocusedultrasoundextracorporealablationoflivertissuesinrabbitsCHENGShuQun1,ZHOUXinDa1,TANGZ... HighintensityfocusedultrasoundextracorporealablationoflivertissuesinrabbitsCHENGShuQun1,ZHOUXinDa1,TANGZhaoYou1,YUYao1,B... 展开更多
关键词 LIVER neoplasms experimental/therapy ultrasonic THERAPY iodized oil/therapeutic use liver/radiation effects randomized controlled trials
下载PDF
Controversies regarding transplantation of mesenchymal stem cells
10
作者 Tsvetelina Velikova Tereza Dekova Dimitrina Georgieva Miteva 《World Journal of Transplantation》 2024年第2期48-61,共14页
Mesenchymal stem cells(MSCs)have tantalized regenerative medicine with their therapeutic potential,yet a cloud of controversies looms over their clinical tran-splantation.This comprehensive review navigates the intric... Mesenchymal stem cells(MSCs)have tantalized regenerative medicine with their therapeutic potential,yet a cloud of controversies looms over their clinical tran-splantation.This comprehensive review navigates the intricate landscape of MSC controversies,drawing upon 15 years of clinical experience and research.We delve into the fundamental properties of MSCs,exploring their unique immuno-modulatory capabilities and surface markers.The heart of our inquiry lies in the controversial applications of MSC transplantation,including the perennial debate between autologous and allogeneic sources,concerns about efficacy,and lingering safety apprehensions.Moreover,we unravel the enigmatic mechanisms surro-unding MSC transplantation,such as homing,integration,and the delicate balance between differentiation and paracrine effects.We also assess the current status of clinical trials and the ever-evolving regulatory landscape.As we peer into the future,we examine emerging trends,envisioning personalized medicine and innovative delivery methods.Our review provides a balanced and informed perspective on the controversies,offering readers a clear understanding of the complexities,challenges,and potential solutions in MSC transplantation. 展开更多
关键词 Mesenchymal stem cells Transplantation controversies Regenerative medicine Autoimmune diseases Chronic inflammatory illnesses Tumor growth METASTASIS therapeutic potential Clinical use of mesenchymal stem cell
下载PDF
USE OF CELL-BASED BIOASSAY FOR THE QUALITY CONTROL OF BOTANICAL THERAPEUTICS
11
作者 Doo Suk Lee Min-Jung Bae Sunyoung Kim 《World Journal of Traditional Chinese Medicine》 2015年第4期91-91,共1页
The single most important factor in modernization efforts of traditional oriental medicines is the limited understanding of active compounds responsible for claimed therapeutic effects.Indeed,the unknown identity of b... The single most important factor in modernization efforts of traditional oriental medicines is the limited understanding of active compounds responsible for claimed therapeutic effects.Indeed,the unknown identity of biologically active molecules generates major difficulties associated with botanical therapeutics in general.This includes management of raw materials,poor understanding of 展开更多
关键词 use OF CELL-BASED BIOASSAY FOR THE QUALITY CONTROL OF BOTANICAL therapeuticS PG
原文传递
Synaptotagmin 1在成年期甲减大鼠海马内表达变化及甲状腺素治疗效应 被引量:3
12
作者 徐永霞 王迅 +1 位作者 沈玉先 朱德发 《安徽医科大学学报》 CAS 北大核心 2009年第6期670-673,共4页
目的研究成年期甲状腺功能减退症(甲减)大鼠海马突触小体内突触结合蛋白1(syt1)的表达量及甲状腺素替代治疗后的恢复状况,探讨甲减脑损伤及恢复的分子基础。方法用丙基硫氧嘧啶(PTU)建立成年期大鼠甲减模型,采用Western blot方法分析甲... 目的研究成年期甲状腺功能减退症(甲减)大鼠海马突触小体内突触结合蛋白1(syt1)的表达量及甲状腺素替代治疗后的恢复状况,探讨甲减脑损伤及恢复的分子基础。方法用丙基硫氧嘧啶(PTU)建立成年期大鼠甲减模型,采用Western blot方法分析甲减组、小剂量甲状腺素替代治疗组、大剂量甲状腺素替代治疗组、正常对照组大鼠海马内syt1的表达情况。结果甲减组大鼠血清T3、T4水平显著低于正常对照组(P<0.05);背侧海马突触小体内syt1的蛋白表达水平显著低于正常对照组(P<0.05)。小剂量甲状腺素替代治疗后,血清T3、T4恢复至正常水平;syt1蛋白表达水平与甲减组比较未见明显改变(P>0.05)。经大剂量替代治疗后血清T3、T4高于正常;syt1的蛋白表达恢复到正常水平(P<0.05)。结论成年期甲减大鼠海马内syt1蛋白表达降低,甲状腺素治疗能使其恢复,且恢复的程度与甲状腺素的治疗剂量有关,大剂量替代治疗较小剂量效果好。 展开更多
关键词 甲状腺功能减退症/药物疗法 突触结合蛋白1 海马 甲状腺素/治疗应用
下载PDF
甲状腺功能亢进症应用黄芪酸枣仁汤治疗效果研究 被引量:4
13
作者 武文平 孟晶晶 +1 位作者 张薇 佟瑞 《世界中医药》 CAS 2020年第24期3802-3805,共4页
目的:探讨甲状腺功能亢进症应用黄芪酸枣仁汤治疗效果。方法:选取2018年1月至2019年12月秦皇岛市中医医院收治的甲状腺功能亢进症患者280例作为研究对象,按照随机数字表法分为对照组(n=135)和观察组(n=145),对照组给予甲巯咪唑治疗,观... 目的:探讨甲状腺功能亢进症应用黄芪酸枣仁汤治疗效果。方法:选取2018年1月至2019年12月秦皇岛市中医医院收治的甲状腺功能亢进症患者280例作为研究对象,按照随机数字表法分为对照组(n=135)和观察组(n=145),对照组给予甲巯咪唑治疗,观察组在对照组治疗的基础上加用黄芪酸枣仁汤进行干预,并数据比较2组患者最后的临床结局。结果:观察组患者临床治疗有效率为97.93%(142/145)显著高于对照组86.67%(117/135),(P<0.05);研究患者治疗后血清甲状腺素中TT3、TT4、FT3、FT4指标均低于对照组,TSH高于对照组(P<0.05);观察组患者在干预后,获得的各项中医症候积分,相较于对照组明显较低(P<0.05);观察组患者的不良反应发生率为2.07%(3/145)显著小于对照组11.85%(16/135)(P<0.05)。结论:黄芪酸枣仁汤治疗甲状腺功能亢进症的里才能效果确切,应用后可显著改善患者清甲状腺素水平,减少患者不良反应情况,可推广使用。 展开更多
关键词 甲状腺功能亢进症 黄芪酸枣仁汤 治疗效果 血清甲状腺素 不良反应
下载PDF
抑减胶囊配合小剂量甲状腺素治疗骨质疏松症疗效观察 被引量:3
14
作者 曹金梅 张英 李燕 《中医正骨》 2003年第11期9-10,共2页
为观察中西医结合治疗骨质疏松症的效果 ,寻求骨质疏松症更有效的治疗方法 ,运用中药抑减胶囊配合小剂量甲状腺激素治疗骨质疏松症 4 8例 ,并与葡萄糖酸钙片 30例作对照。结果显示 :治疗组有效率 97.92 % ,对照组有效率 86 .6 7% ,两组... 为观察中西医结合治疗骨质疏松症的效果 ,寻求骨质疏松症更有效的治疗方法 ,运用中药抑减胶囊配合小剂量甲状腺激素治疗骨质疏松症 4 8例 ,并与葡萄糖酸钙片 30例作对照。结果显示 :治疗组有效率 97.92 % ,对照组有效率 86 .6 7% ,两组比较治疗组明显优于对照组 (P <0 .0 5 ) ,骨密度增加值比较 ,治疗组也明显高于对照组 (P <0 .0 5 )。认为中药配合小剂量甲状腺激素是治疗骨质疏松症的有效方法之一。 展开更多
关键词 骨质疏松症 中西医结合 抑减胶囊 治疗 甲状腺激素
下载PDF
“甲亢灵”治疗甲状腺机能亢进症的临床观察 被引量:9
15
作者 廖世煌 陈纪藩 +1 位作者 黄仰模 郭凤莲 《广州中医学院学报》 1991年第2期145-149,共5页
本文收治73例甲亢患者,其中甲亢灵组60例,他巴唑组13例。甲亢灵组服用甲亢灵(中药基本方加少量他巴唑制成药片,他巴唑每天摄入量为他巴唑组的50%,他巴唑组服用他巴唑、心得安等。3个月为1疗程。结果甲亢灵组总有效率96.7%.其中缓解率6... 本文收治73例甲亢患者,其中甲亢灵组60例,他巴唑组13例。甲亢灵组服用甲亢灵(中药基本方加少量他巴唑制成药片,他巴唑每天摄入量为他巴唑组的50%,他巴唑组服用他巴唑、心得安等。3个月为1疗程。结果甲亢灵组总有效率96.7%.其中缓解率63.3%;他巴唑组总有效率77%,其中缓解率30.8%。两组间总有效率及缓解率比较,差别均有显著性意义(P<0.05),说明甲亢灵组疗效高于他巴唑。治疗前后两组患者血清T_3、T_4含量下降的差值比较,差别无显著性意义(P>0.05),说明两组降T_3、T_4的效果相近.疗效指数计分甲亢灵组(3.31±2.53)与他巴唑组(5.15±2.6)比较,差别有显著性意义(P<0.01),说明甲亢灵组能较好地改善临床症状.在治疗过程中,甲亢灵组未见毒副反应发生;他巴唑组发现皮疹3例,白细胞减少2例,肝功受损2例。本文还观察到甲亢患者血液流变性有异常改变,经甲亢灵治疗后,降低了血液粘聚性,对病情改善有一定作用。我们体会到,益气养阴是治疗甲亢的重要法则;还要清热泻火以护气阴;化痰散结、活血袪瘀应贯穿治疗始终。甲亢灵疗效高、毒副反应少,除应用较少量的他巴唑外,中药基本方对改善临床症状、体征、降低T_3、T_4、防止或减轻毒副反应等方面,具有重要的作用。 展开更多
关键词 甲亢灵 甲亢 中西医结合 血液粘度
下载PDF
甲状腺激素治疗老年充血性心力衰竭的临床观察
16
作者 汪斌 单炳南 王钧 《药学与临床研究》 2007年第5期403-405,共3页
目的:观察老年充血性心力衰竭(CHF)患者甲状腺激素水平及甲状腺激素治疗的效果。方法:将86例老年CHF患者随机分为两组,在常规治疗的基础上,治疗组加用甲状腺片10-20mg/d,2周为一疗程。结果:治疗组治疗后三碘甲状腺原氨酸(T3... 目的:观察老年充血性心力衰竭(CHF)患者甲状腺激素水平及甲状腺激素治疗的效果。方法:将86例老年CHF患者随机分为两组,在常规治疗的基础上,治疗组加用甲状腺片10-20mg/d,2周为一疗程。结果:治疗组治疗后三碘甲状腺原氨酸(T3)明显上升(P〈0.05);治疗组总有效率高于对照组(X^2=9.53,P〈0.01);心功能显著改善相关,心功能Ⅳ级患者改善更明显(P〈0、05)。结论:CHF患者大多数体内甲状腺激素水平降低,适当地补充甲状腺激素对老年CHF治疗奄盏, 展开更多
关键词 老年患者 充血性心力衰竭(CHF) 甲状腺激素
下载PDF
成年期甲减大鼠海马Munc18表达及甲状腺素的治疗效应 被引量:4
17
作者 叶启宝 朱德发 +3 位作者 贾雪梅 刘春蕾 杨会云 马维青 《安徽医科大学学报》 CAS 北大核心 2009年第4期423-426,共4页
目的观察成年期甲状腺功能减退症(简称甲减)大鼠海马神经突触前膜胞内蛋白Munc18表达及常规剂量和大剂量替代治疗后的变化。方法用丙基硫氧嘧啶(PTU)建立成年期大鼠甲减及治疗模型,放射免疫法测定血清甲状腺素水平,免疫组织化学法观察Mu... 目的观察成年期甲状腺功能减退症(简称甲减)大鼠海马神经突触前膜胞内蛋白Munc18表达及常规剂量和大剂量替代治疗后的变化。方法用丙基硫氧嘧啶(PTU)建立成年期大鼠甲减及治疗模型,放射免疫法测定血清甲状腺素水平,免疫组织化学法观察Munc18在大鼠海马结构的表达与分布。结果与正常对照组比较,甲减大鼠血清T3、T4水平减低,差异有统计学意义,常规剂量替代治疗后恢复正常,大剂量替代治疗后升高,差异有统计学意义。免疫组织化学法显示甲减组海马CA3区、齿状回(DG)和CA1区多形层的Munc18平均光密度值减低,常规剂量替代治疗后,仅DG区分子层平均光密度值减低,大剂量替代治疗后,其差异无统计学意义。结论成年期甲减可致海马内Munc18蛋白表达减少,常规剂量甲状腺素替代治疗能使其大部分恢复,大剂量替代治疗能全部恢复。 展开更多
关键词 甲状腺功能减退症 海马 甲状腺素/治疗应用 Munc18
下载PDF
Combination of "low-dose" ribavirin and interferon alfa-2a therapy followed by interferon alfa-2a monotherapy in chronic HCV-infected nonresponders and relapsers after interferon alfa-2a monotherapy 被引量:19
18
作者 Perdita Wietzke-Braun Volker Meier +1 位作者 Felix Braun Giuliano Ramadori 《World Journal of Gastroenterology》 SCIE CAS CSCD 2001年第2期222-227,共6页
AIM To report on the efficacy, safety and tolerability of interferon alfa-2a combined with a "low dose" of ribavirin for relapsers and non responders to alpha interferon monotherapy.METHODS Thirty-four chron... AIM To report on the efficacy, safety and tolerability of interferon alfa-2a combined with a "low dose" of ribavirin for relapsers and non responders to alpha interferon monotherapy.METHODS Thirty-four chronic hepatitis C virus-infected non-responders to interferon alfa2a monotherapy (a course of at least 3 months treatment) and 13 relapsers to interferon alfa 2a monotherapy (a dose of 3 to 6 million units three times per week for at least 20 weeks but not more than 18 months) were treated with the same dose of interferon alfa-2a used before (3 to 6 million units three times per week) and ribavirin (10 mg/ kg daily) for 6 months. In complete responders, interferon alfa-2a was administered for further 6 months at the same dose used before as monotherapy.RESULTS Seven (20.6%) of 34 non-responders stopped the combined therapy due to adverse events, including two patients with histological and clinical Child A cirrhosis. In 17/27 (63%)non-responders, the combined therapy was stopped after three months because of non-response. Ten of the 27 non-responders completed the 1;2-month treatment course. At a mean follow up of 28 months (16- 37 months)after the treatment, 4/10 (15%) previous non-responders still remained complete responders,All 13 previous relapsers completed the 12-month treatment course. At a mean follow up of 22months (9 - 36 months) after treatment, 6/13(46%) the previous relapsers were stillsustained complete responders.CONCLUSION Our treatment schedule of the combined therapy for 6 months of interferon alfa2a with a low dose of ribavirin (10 mg/kg/day)followed by 6 months of interferon alfa-2amonotherapy is able to induce a sustainedcomplete response rate in 15% of non-responders and 46% of relapsers with chronic hepatitis C virus-related liver diseases comparable to those obtained with the standarddoses of ribavirin 1000 - 1200 mg/day.Randomized prospective controlled trials using lower total amounts of ribavirin in combination with interferon should be performed. 展开更多
关键词 hepatitis C chronic/drug therapy INTERFERON alpha-2a/therapeutic use INTERFERON alpha-2a/administration & DOSAGE ribavirin/administration & DOSAGE ribavirin/therapeutic use
下载PDF
Probiotic mixture VSL#3:An overview of basic and clinical studies in chronic diseases 被引量:11
19
作者 Fang-Shu Cheng Dan Pan +2 位作者 Bing Chang Min Jiang Li-Xuan Sang 《World Journal of Clinical Cases》 SCIE 2020年第8期1361-1384,共24页
Probiotics are known as“live microorganisms”and have been proven to have a health effect on hosts at the proper dose.Recently,a kind of probiotic mixture including eight live bacterial strains,VSL#3,has attracted co... Probiotics are known as“live microorganisms”and have been proven to have a health effect on hosts at the proper dose.Recently,a kind of probiotic mixture including eight live bacterial strains,VSL#3,has attracted considerable attention for its combined effect.VSL#3 is the only probiotic considered as a kind of medical food;it mainly participates in the regulation of the intestinal barrier function,including improving tight junction protein function,balancing intestinal microbial composition,regulating immune-related cytokine expression and so on.The objective of this review is to discuss the treatment action and mechanism for the administration of VSL#3 in chronic diseases of animals and humans(including children).We found that VSL#3 has a therapeutic or preventive effect in various systemic diseases per a large number of studies,including digestive systemic diseases(gastrointestinal diseases and hepatic diseases),obesity and diabetes,allergic diseases,nervous systemic diseases,atherosclerosis,bone diseases,and female reproductive systemic diseases. 展开更多
关键词 VSL#3 INTESTINAL barrier function CHRONIC DISEASES INTESTINAL MICROBIAL balance CYTOKINES therapeutic use
下载PDF
Medicinal plants with hepatoprotective activity in Iranian folk medicine 被引量:5
20
作者 Majid Asadi-Samani Najme Kafash-Farkhad +3 位作者 Nafiseh Azimi Ali Fasihi Ebrahim Alinia-Ahandani Mahmoud Rafieian-Kopaei 《Asian Pacific Journal of Tropical Biomedicine》 SCIE CAS 2015年第2期146-157,共12页
There are a number of medicinal combinations in the Iranian traditional medicine which are commonly used as tonic for liver.In this review,we have introduced some medicinal plants that are used mainly for the treatmen... There are a number of medicinal combinations in the Iranian traditional medicine which are commonly used as tonic for liver.In this review,we have introduced some medicinal plants that are used mainly for the treatment of liver disorders in Iranian folk medicine,with focus on their hepatoprotective effects particularly against CCI_4 agent.In this study,online databases including Web of Science.PubMed.Scopus,and Science Direct were searched for papers published from January 1970 to December 2013.Search terms consisted of medicinal plants,traditional medicine,folk medicine,hepatoprotective.Iran,liver,therapeutic uses,compounds,antioxidant.CCI_4.anti-inflammatory,and antihepatotoxic,hepatitis,alone or in combination.Allium hirtifolium Boiss..Apium graveolens L..Cynara scolyinus.Berberis vulgaris L..,Calendula officinalis,Nigella sativa L..Taraxacum officinale.Tragopogon porrifolius.Prangos ferulacea L..Allium sativum,Marribium vulgare,Ammi majus L..Citrullus lanatus Thunb.Agrimonia eupatoria L.and Primus armeniaca L.are some of the medicinal plants that have been used for the treatment of liver disorders in Iranian folk medicine.Out of several leads obtained from plants containing potential hepatoprotective agents,silymarin,P-sitosterol,betalain,neoandrographolide.phyllanthin.andrographolide.curcumin.picroside.hypophyllanlhin.kutkoside,and glycyrrhizin have been demonstrated to have potent hepatoprotective properties.Despite encouraging data on possibility of new discoveries in the near future,the evidence on treating viral hepatitis or other chronic liver diseases by herbal medications is not adequate. 展开更多
关键词 Medicinal plants Iran COMPOUNDS LIVER therapeutic uses CCl_4
下载PDF
上一页 1 2 3 下一页 到第
使用帮助 返回顶部